Valuation: Pharmena S.A.

Market Cap 34.42M 9.13M 7.96M 7.43M 6.84M 12.84M 870M 13.12M 88.04M 434M 34.26M 33.53M 1.49B P/E 2024
-33.8x
P/E 2025 -10.4x
Enterprise Value 34.42M 9.13M 7.96M 7.44M 6.84M 12.84M 870M 13.12M 88.06M 434M 34.27M 33.54M 1.49B EV / Sales 2024
154x
EV / Sales 2025 18.4x
Free-Float
29.7%
Yield 2024 *
-
Yield 2025 -
1 week-0.32%
Current month-1.90%
1 month+0.32%
3 months-6.93%
6 months-13.45%
Current year+18.85%
1 week 3.05
Extreme 3.05
3.17
1 month 3.02
Extreme 3.02
3.18
Current year 2.56
Extreme 2.56
4.32
1 year 2.5
Extreme 2.5
4.32
3 years 2.5
Extreme 2.5
9.18
5 years 2.5
Extreme 2.5
10.96
10 years 2.5
Extreme 2.5
33.48
Manager TitleAgeSince
Chief Executive Officer - 11/11/2002
Chief Tech/Sci/R&D Officer - 31/03/2008
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 63 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.32%-12.71%-58.58% 9.07M
+0.16%+1.25%+2.65%-8.87% 233B
+0.08%+1.20%+32.46% - 50.79B
-2.55%-10.96%+94.03% - 8.58B
+7.01%+8.34%+43.52%-43.55% 7.94B
+2.61%+1.84%-6.88%+10.02% 5.06B
-3.80%+1.25%-33.11%-30.22% 4.96B
-0.50%+3.43%+1.55%-15.49% 4.09B
+1.44%+5.74%-26.63%-47.40% 3.49B
-1.80%-0.73%-46.99%-77.21% 2.45B
Average +0.27%+0.82%+4.79%-33.91% 32.03B
Weighted average by Cap. +0.21%+0.91%+9.42%-11.23%

Financials

2024 2025
Net sales 268K 71.08K 62K 57.88K 53.25K 99.96K 6.77M 102K 686K 3.38M 267K 261K 11.64M 1.58M 418K 365K 341K 313K 588K 39.86M 601K 4.03M 19.87M 1.57M 1.54M 68.48M
Net income -1.26M -335K -292K -273K -251K -471K -31.9M -481K -3.23M -15.9M -1.26M -1.23M -54.8M -2.77M -734K -641K -598K -550K -1.03M -70M -1.06M -7.08M -34.89M -2.76M -2.7M -120M
Net Debt -1.5M -398K -347K -324K -298K -560K -37.94M -572K -3.84M -18.91M -1.49M -1.46M -65.18M 9K 2.39K 2.08K 1.94K 1.79K 3.36K 228K 3.43K 23.02K 113K 8.96K 8.77K 391K
Logo Pharmena S.A.
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Employees
7
Date Price Change Volume
29/07/26 PLN 3.090 0.00% 1,211
28/07/26 PLN 3.090 -0.32% 566
27/07/26 PLN 3.100 -0.32% 432
24/07/26 PLN 3.110 -1.58% 3,455
23/07/26 PLN 3.160 -0.32% 36